Prenatal identification of a pathogenic maternal FGFR1 variant in two consecutive pregnancies with fetal forebrain malformations

Holoprosencephaly (HPE) is the most common aberration of forebrain development, and it leads to a wide spectrum of developmental and craniofacial anomalies. HPE etiology is highly heterogeneous and includes both chromosomal abnormalities and single-gene defects. Here, we report an heterozygous varia...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of maternal-fetal & neonatal medicine 2024-12, Vol.37 (1), p.2344718-2344718
Hauptverfasser: Graziani, Ludovico, Nuovo, Sara, Pisaneschi, Elisa, Carriero, Miriam Lucia, Baghernajad Salehi, Leila, Nardone, Anna Maria, Manganaro, Lucia, Novelli, Antonio, D'Apice, Maria Rosaria, Mappa, Ilenia, Novelli, Giuseppe
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Holoprosencephaly (HPE) is the most common aberration of forebrain development, and it leads to a wide spectrum of developmental and craniofacial anomalies. HPE etiology is highly heterogeneous and includes both chromosomal abnormalities and single-gene defects. Here, we report an heterozygous variant detected by prenatal exome sequencing and inherited from the asymptomatic mother, in association with recurrent neurological abnormalities in the HPE spectrum in two consecutive pregnancies. Individuals with germline pathogenic variants in (MIM: 136350) show extensive phenotypic variability, which ranges from asymptomatic carriers to hypogonadotropic hypogonadism, arhinencephaly, Kallmann's syndrome with associated features such as cleft lip and palate, skeletal anomalies, isolated HPE, and Hartsfield syndrome. The presented case supports the role of exome sequencing in prenatal diagnosis when fetal midline structural anomalies are suggestive of a genetic etiology, as early as the first trimester of gestation. The profound heterogeneity of allelic disorders needs to be considered when planning prenatal screening even in asymptomatic carriers.
ISSN:1476-7058
1476-4954
DOI:10.1080/14767058.2024.2344718